INTRODUCTION
Hepatocellular carcinoma (HCC) is a highly malignant cancer and it is the sixth most common cancer worldwide and the third most common cause of cancer related deaths with higher prevalence in Asia and sub-Saharan Africa [1] .
Advancement in diagnostic radiology and nuclear medicine contributed to the accurate and early diagnosis of HCC. Ultasound, CT, Triphasic CT and MRI are used in diagnosis of these tumors [2] . Surgical resection, liver transplantation and cryosurgery are considered the best curative options for HCC. Regional interventional therapies have led to a major breakthrough in the management of unresectable HCC [3] .
Furthermore, experiences in interventional radiology, radiation oncology and surgery fields have grown, and new therapeutic choices have been developed including percutaneous ablation therapy, transarterial chemoembolization (TACE), radiation therapy and molecular target therapy [4] . Ablation of liver tumors is currently the main alternative to formal liver resection [5] . Percutaneous ethanol injection (PEI) is a procedure of easy execution, good tolerability and low cost, which can be applied in repeated sessions [2] .
Mitoxantrone is a cycle specific anthracyclin which induces persistent intracellular DNA damage. It is used as an anticancer agent and has demonstrated clinical activity when administered via multiple routes: intravenous, intraperitoneal, intrapleural, intrapericardial, or intrathecal [6] . Mitoxantrone was selected for palliative local treatment of malignant liver lesions because of its low tissue toxicity, high intratumoral concentration after intratumoral instillation, since it has a tendency to remain at the application site [7] .
This work aimed at comparing PEI with combined PEI and intralesional mitoxantrone(PIM) in treatment of HCC.
PATIENTS AND METHODS
This prospective interventional study was conducted in Tropical medicine and Clinical Oncology Departments, Faculty of Medicine, Zagazig university, Egypt, during the period from February 2009 to May 2011 and included 125 patients presented with 131 focal hepatocellular carcinoma lesions, the lesions were randomly divided into 2 groups; Group I: Comprised 68 focal lesions presented in 65 patients ,which were injected intralesionally with ethanol in multiple sessions.
Group II:
Comprised 63 focal lesions presented in 60 patients, which were injected intralesionally with ethanol in multiple sessions followed by intralesional injection with Mitoxantrone.
Each focal lesion was considered as one subject.
The diagnosis of HCC was based on typical characters of focal lesion in triphasic CT: filling of the dye in arterial phase and rapid fade out in venous and delayed phases, CT and∕or ultrasound focal lesions with a serum alpha-fetoprotein >200 IU/ml or by histological confirmation. 
Pretreatment assessment
Pre-treatment assessment of all patients was done by full history taking, thorough clinical examination, laboratory investigations including CBC, liver function, kidney function, α fetoprotein, serological examination for HCV and HBV. Radiological examination including X ray chest , CT study, ultrasound and ultrasound guided biopsy when indicated.
Ethanol injection.
All lesions were injected by absolute alcohol; ultrasound guided in multiple sessions, twice weekly, under complete aseptic condition and 10 mg midazolam as a sedative agent.
The same operator used spinal needle (20 gauge) to inject ethanol intralesionally and leave the needle for 2 minutes in place, then injection of local anesthetic during withdrawal of the needle to minimize the irritant effect of refluxed ethanol to the capsule.
The total amount of ethanol can be calculated according to the following equation: V=4/3 π(r+0.5)³ Where: V=Volume of ethanol, π= 22/7, r = radius of the tumor by cm plus 0.5 cm as safety margin [10] .
The average amount per session was 6.8 cc, with average 5 sessions per lesion and average amount of 35 cc per lesion which was calculated according to the above mentioned equation used by Shiina et al [10] .
Mitoxantrone injection.
This was done to patients of group II after complete sessions of ethanol.
Ultrasound guided injection of mitoxantrone mixed with lipidol at the time of injection in a single session, the dose of mitoxantrone is 0.5 mg per cubic centimeter of the tumor size. Re-evaluation of the patients was done by laboratory investigations, ultrasound and triphasic CT after treatment and every 3 moths up to one year.
Statistical analysis
Data were checked, entered and analyzed using SPSS 15 for Windows. Data were expressed as mean ± SD for quantitative variable, number and percentage for qualitative one. Chi-squared (X 2 ) or fisher exact, t test and paired t test were used when appropriate. P <0.05 was considered significant.
RESULTS
Clinical presentations of the studied patients is shown in table 1. Group I included 48 male patients and 17 females with a mean age of 61.1 years. Group II included 44 male patients and 16 females with a mean age of 60 years. There was no statistically significant difference as regard age and sex between the studied groups .
Chronic HCV infection was the predominant virus in our study, 112 patients were HCV antibodies positive ,where 11 patients were HBsAg positive and two patients had coinfection of both viruses. Local ablation therapy for HCC is associated with a variety of complications as shown in table (2) . The most frequent complication was tolerable pain while intolerable pain (needs analgesics) detected in 27.6% and 20% of patients in group I and group II respectively. The most serious complications were less frequent and tend to occur in subjects in group I who developed peritoneal collection, subcapsular hematoma and pleural effusion each one detected in 2 subjects (3.1%) , while portal vein thrombosis detected in 3 subjects(4.6%). All these complications were controlled by conservative management . Table ( 3) compares biochemical parameters among patients of groups I before and 3 months after injection, there was no statistically significant difference as regard all parameters except for serum alphafeto protein( α FP) and AST which showed statistically significant improvement after treatment. Table (4) compares biochemical parameters among patients of groups II before and 3 months after injection, there was no statistically significant difference as regard to αFP , AST, serum bilirubin( BIL),serum albumin ( ALB) and serum creatinin (CRT) , where ALT and prothrombin time (PT) show statistically significant improvement in these patients after injection. Table 5 and 6 compare the success of ablation and rate of recurrence at 3 ,6 and 12 months with good ablation recorded in group II than in group I. 
DISCUSSION
Percutaneous ablation is the best treatment option for patients with early stage HCC who are not suitable for surgical resection or transplantation [8] . Ethanol induces immediate coagulative necrosis and injury then thrombosis of tumor cells and enable the complete ablation of small neoplastic lesions without adversely affecting liver function.PEI is a procedure of easy execution, good tolerability and low cost, which can be applied in repeated sessions [2] and that is why we used this maneuver for percutanous ablation in our low resource community. PEI performed under ultrasonographic guidance achieves complete tumor necrosis in 70%-80% of solitary HCC ≤ 3cm [11] and in almost 100% in tumors less than 2 cm. Tumor necrosis is less likely to be achieved in large tumors; 70% necrosis is reported for tumors between 2 and 3 cm and 50% necrosis for HCC between 3 and 5 cm [12] .
The median age of patients in this study is 60.7 years which is slightly higher than ages recorded in another Egyptian study and estimated to be 56 years [13] , and this may be due to improvement of general health by preventive programs and introduction of antiviral agents in treatment of chronic HCV and HBV.
In our study the male (n=92) to female (n=33) ratio was 2.7:1, which is in agreement with both the local Egyptian ratio 3:1 stated by Gad ElMawla et al. [13] , and the international ratios of 2.6:1 in China and 3.1:1 in Italy [14] .
HCC usually develops following chronic liver inflammation caused by hepatitis C or B virus [15] . This is also applied to our study where chronic HCV infection is the most common cause of liver disease in our series (89.6% of patients versus 8.8% chronic HBV and 1.6% cases of coinfection) and this reflects the situation in Egypt where HCV prevalence
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reported among several population groups reachs up to 20 % [16] , while low prevalence of chronic HBV coincide with intermediate endemicity (2-8%) of HBsAg carrier rate in Egypt [17] . These results are not in agreement with Abdel-Wahab et al., [18] who found positive virology in only 82.5% of HCC patients (61% HCV, 14.5% HBV and 7% coinfection), this may be attributed to the advancement in the diagnostic methods .
Abdominal pain (right upper quadrant), anorexia and loss of weight were the most common presenting symptoms, while liver cirrhosis and splenomegaly were the predominant signs, this is in agreement with Kew [19] .
As regard treatments for HCC, liver transplantation can eliminate tumors and cirrhosis at the same time, and is considered to be the most appropriate treatment for patients with early HCC [20] . But, the lack of liver donors is a major limitation [21] . In Egypt further obstacles include high prevalence of chronic liver diseases in particular HCV in addition to financial constraints for the high cost of transplantation and the lack of experience for living donor liver transplantation.
Till the time this study is planned for in February 2009, many studies had been published to evaluate effect of percutanous injection of ethanol in treatment of HCC,but few studies evaluating percutanous injection of mitoxantrone in treatment of HCC were published and none -to our knowledge-evaluated effect of percutanous combined injection of ethanol and mitoxantrone in treatment of HCC.
In a study done by Sung et al; [22] between January 1995 and April 1999, 64 patients with HCC were treated by PEI as first-line treatment and therapeutic efficacy was assessed by US ,CT and AFP. Overall survival rates at one year was 92% and the corresponding cancer free survival rates were 56%. The local tumor progression rates were 23% (9 of 39 HCCs ) for tumors ≤ 2cm in diameter . The local tumor recurrence is comparable to our results(19.5%), while the survival rate is better in their study due to different etiology of their patients as HCC develop in chronic hepatitis B viral infection with good synthetic function of the liver.
In our study the percentage of complete ablation in group I at 3, 6,12 months after the use of PEI alone is 60%,48.5% and 39.7% respectively. Which is in agreement with Sung and his colleagues [22] who obtain the same percentage of ablation in large lesions 2-5 cm in diameter.
The use of combined PEI and PIM resulted in a significantly higher rates of complete ablation at 3, 6 and 12 months: 85.7%, 74.6% and 68%, respectively and indicate the efficacy of mitoxantrone addition to PEI. These results may attributed to effect of ethanol on blood vessels draining the tumor leading to their thrombosis that impair systemic absorption of mitoxantrone and maximize its local effect.
Lipidol has high affinity to malignant hepatocytes, when mixed with mitoxantrone leads to selective uptake by malignant hepatocytes leading to additional ablative effect and more prevention of local recurrence rate observed in group II compared to group I.
The percentage of ablation after treatment with combination of PEI and PIM is 85.7% after 3 months, These results are comparable with many studies reporting similar frequency of ablation after radiofrequency ablation (RF) in patients with similar criteria [23] . We are in need for further controlled studies to compare RF and combination of PEI and PIM.
Intratumoral instillation of mitoxantrone results in a 1000-fold higher concentration in the tumor compared with intravenous administration. We preferred to do percutaneous interventions to obtain a higher drug concentration within the tumor without systemic toxicity and to preserve the integrity of the healthy liver parenchyma, which is an advantage over (TACE) or repeated surgery .This factor is of paramount importance as survival is dependent on the integrity of the liver function [24] .
Farres et al. [25] evaluated PIM in hepatic focal lesions. They used 10 mg of mitoxantrone for lesions < 3 cm and 20 mg for lesions >3cm. Three treatment sessions were performed 1 month apart for each of the 11 lesions. Follow-up by CT examination one month after therapy showed very low attenuation of the lesion indicating tumor necrosis. All injections were painless except four and patients never required analgesics during or after the procedure. Doses of 10-20 mg PIM produces no side effects and no hematologic toxicity was observed [25] . When we compare these results with our results, there were higher rate of intolerable pain, fever and vomiting and other local aggressive complications, ethanol injection would be accused as the cause of these complications.
The histologic effects of locoregional mitoxantrone treatment are characterized by complete tumor necrosis in which dead tumor cells are surrounded by an inflammatory infiltrate and a fibrotic organization of liver tissue around the tumor [26] .This structure tends to isolate the lesion , preventing their expansion and promoting the persistence of the drug at the injected site . This fibrous rim reaction could also explain why lesion remain stable and do not shrink after PIM treatment. Furthermore this rim could prevent proliferation of residual cancer cells [25] and this explain absence of aggressive local complications in group II of our study e.g. peritoneal reaction.
The drawback of PIM as with all localized treatments is that it does not preclude the emergence of other tumor foci or the progression of untreated tumors [25] .
In this study the rate of local recurrence is higher in group I in comparison to group II and this additional benefit may be attributed to PIM and its induced perilesional fibrous reaction.
In this study the synthetic liver functions and consequently Child class seems to be improved in group II than group I and hence combined use of PEI and PIM seems to be superior to PEI alone.
In conclusion, PEI followed by PIM seems to be better than PEI alone and this is reflected by higher rates of complete ablation of focal hepatic lesions at 3,6 and 12 months. Improvement of synthetic liver functions and consequently Child classes is better in group II than group I.
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